Protocol summary

Study aim
Determining and comparing the trend of changes in the approximate area of the wound and the formation of scars around it in patients with second degree burn wounds between the two groups of nanofibers (placebo) and nanofibers containing the extract of Pagaze plant from the first day to the fifth week
Design
A placebo controlled, triple blind, parallel group, randomized, phase 2-3 clinical trial on 54 patients. The rand function of Excel software will be used for randomization
Settings and conduct
Three groups of patients referring to Imam Khomeini Hospital in Kermanshah will be randomly selected and will be visited by the attending physician. After washing the wound by the nurse and applying the physician's orders on the wound, a group of nanofibers containing plant extract will be placed on the wound, and a placebo will be placed on the wound of another group, and the third group will be without intervention, then the wounds will be covered with sterile gauze and the dressings will be changed daily in the same way. Patients, clinical staff, statistical consultant and outcome evaluator were blinded
Participants/Inclusion and exclusion criteria
The inclusion criteria: patients with second degree burns who refer to Imam Khomeini Hospital in Kermanshah and are between 15 and 90 years old. Exclusion criteria: those patients who are pregnant or breastfeeding or are being treated with cytotoxic drugs or radiotherapy or have a survival chance of less than three months.
Intervention groups
The control group will receive only the conventional treatment (sterile gauze dressing along with the drugs prescribed by the attending physician) In addition to conventional treatment, the other two groups will be dressed with nanofibers containing Pagaze extract or nanofibers without Pagaze extract (placebo)
Main outcome variables
Approximate wound area; scar formation

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20130722014106N10
Registration date: 2023-08-05, 1402/05/14
Registration timing: prospective

Last update: 2023-08-05, 1402/05/14
Update count: 0
Registration date
2023-08-05, 1402/05/14
Registrant information
Name
Reza Tahvilian
Name of organization / entity
Kermanshah University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 83 1427 6482
Email address
rtahvilian@kums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-08-23, 1402/06/01
Expected recruitment end date
2023-10-23, 1402/08/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Preparation of Nano fiber Containing Pagaze (Falcaria vulgaris) Extract and Studying its Effect on Second-degree Burn Injury Healing Process Compared to Conventional Sterile Gauze Dressing: An Experimental-Clinical Trial Study
Public title
Synthesis and Evaluation of the Effect of F.vulgaris Nanofibers on Burn Wounds
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Having second-degree burn Referred to "Imam Khomeini" Hospital, Kermanshah, Iran
Exclusion criteria:
The survival chance be less than three months Use cytotoxic drugs or radiotherapy Pregnancy or lactation
Age
From 15 years old to 90 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
  • Care provider
  • Data analyser
Sample size
Target sample size: 57
Randomization (investigator's opinion)
Randomized
Randomization description
The samples will be selected by the random block method with blocks of 4 and using the rand function of the Excel software, a random sequence by a person not involved in the research (therapist). Registration of people is done by the clinic reception. Blocking and allocation sequence for concealment will be done by a person not involved in the research (therapist). The ratio of allocation of samples will be 1:1. A placebo with the same appearance as F.vulgaris extract is used to hide the randomization.
Blinding (investigator's opinion)
Triple blinded
Blinding description
The dressings are prepared by the nanofiber manufacturer researcher in the same and numbered packaging for both groups A and B. The manufacturer's investigators will be unaware of which package will be used for which patient. It will be explained to the patients that you will receive the usual treatments, in addition, it is possible that the extract of the F.vulgaris extract will be used to heal your wound, and the clinical staff will not know exactly for whom this plant extract was used. The clinical staff and the analyst are unaware of which dressing is placebo and which dressing contains drug. The outcome evaluator is the researcher who made the dressing.
Placebo
Used
Assignment
Parallel
Other design features
Three groups will be studied: the first group will receive conventional treatments. The second and third groups, in addition to the conventional treatments, will receive one of the dressings containing herbal extract or without it. Subjects will be evaluated for local or systemic allergic reactions, severe infection and toxicity after each dressing, and the study will be stopped if any complications are observed.

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Kermanshah University of Medical Sciences
Street address
Kermanshah, Kermanshah University of Medical Sciences, Shahid Beheshti Blvd.
City
Kermanshah
Province
Kermanshah
Postal code
6714673159
Approval date
2023-05-23, 1402/03/02
Ethics committee reference number
IR.KUMS.REC.1402.075

Health conditions studied

1

Description of health condition studied
Second degree burn injury
ICD-10 code
T30.2
ICD-10 code description
Burn of second degree, body region unspecified

Primary outcomes

1

Description
Approximate wound area
Timepoint
Measurement of the approximate wound area before the start of the intervention and 7, 14, 21, 28 and 35 days after the start of dressing with nanofibers containing Pagaze
Method of measurement
Measuring the approximate dimensions of the wound using a ruler and calculating its area

2

Description
Scar formation
Timepoint
Before the start of the intervention and 7, 14, 21, 28 and 35 days after the start of dressing with nanofibers containing Pagaze
Method of measurement
Observing the formation or non-formation of scars around the wound

Secondary outcomes

empty

Intervention groups

1

Description
First intervention group: after washing and applying conventional treatments, nanofibers containing at least one milligram per square centimeter of Pagaze plant extract will be cut to the dimensions of the wound and will be placed locally on the wound and will be dressed with sterile gauze. Dressing will be done daily until recovery
Category
Treatment - Drugs

2

Description
Second intervention group: after washing and applying conventional treatments, nanofibers without the Pagaze extract will be cut to the dimensions of the wound and will be placed locally on the wound and will be dressed with sterile gauze. Dressing will be done daily until recovery
Category
Placebo

3

Description
Control group: after washing the wound, you will receive the conventional treatments and it will be dressed with sterile gauze. The dressing will be changed daily
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Khomeini hospital
Full name of responsible person
Reza Tahvilian
Street address
Jomhoori Islami Blvd., Saadi
City
Kermanshah
Province
Kermanshah
Postal code
6718743161
Phone
+98 83 3728 3602
Fax
+98 83 3722 4516
Email
ihosp@kums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Cyrus Jalili
Street address
Central building, Kermanshah University of Medical Science, Beheshti Blvd.
City
Kermanshah
Province
Kermanshah
Postal code
6714673159
Phone
+98 83 3837 0541
Fax
+98 83 3838 6835
Email
research_it@kums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kermanshah University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Reza Tahvilian
Position
Scientific member of Kermanshah University of Medical |Sciences
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Shahid Beheshti Street, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6714415153
Phone
+98 83 1427 6482
Fax
+98 83 1427 6493
Email
rtahvilian@kums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Reza Tahvilian
Position
Scientific member of Kermanshah University of Medical |Sciences
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Shahid Beheshti Street, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6714415153
Phone
+98 83 1427 6482
Fax
+98 83 1427 6493
Email
rtahvilian@kums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Reza Tahvilian
Position
Scientific member of Kermanshah University of Medical |Sciences
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
Shahid Beheshti Street, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6714415153
Phone
+98 83 1427 6482
Fax
+98 83 1427 6493
Email
rtahvilian@kums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Age, gender, underlying disease as well as creation or non-creation of scars and the approximate area of the wound before and after the study can be shared
When the data will become available and for how long
The start of the data access period is six months after the publication of the study results
To whom data/document is available
All people working in universities and research centers will be allowed to send requests to receive data
Under which criteria data/document could be used
Data sharing will be possible after receiving an official request from the relevant scientific center and only by clearly stating the reasons for the need to access the information and its use. Obviously, any use of the data outside of the application mentioned by the requester is not allowed
From where data/document is obtainable
Dr. Reza Tahvilian: Faculty of Pharmacy, University of Medical Sciences, Bagh Abrisham, Kermanshah, Iran rtahvilian@kums.ac.ir Dr. Hossein Amiri: Mahdie Clinic, Moayed St., Kermanshah, Iran hossein.amirii@yahoo.com
What processes are involved for a request to access data/document
After sending the request to the relevant researcher and confirming the receipt of the request by him, the requested information will be sent within 15 days
Comments
Loading...